LSTM’s health economists Professor Louis Niessen and Dr Jahangir Khan outline the importance for universal access to medicines in the control of neglected diseases, other major infections, and chronic diseases.
In an editorial in the journal The Lancet Professor Niessen and Dr Khan argue that strategies to make medicines more available and affordable are critical in increasing their use in low- and middle- income countries. There is a double burden of infectious and chronic diseases, while the awareness of the benefits of prevention and treatment has grown.
Their comment comes following the publication of the McMaster University-lead Prospective Urban Rural Epidemiology (PURE) study on the availability and costs of cardiovascular medicine across 18 countries. This landmark health economics study on the empirical costs of medicines with comparisons across both high- and low-income settings, shows that secondary prevention is unavailable and unaffordable in the surveyed 94,919 communities across the world. Professor Niessen and Dr Khan argue that its findings are important in the formulation of policies on universal health coverage and the mobilisation and use of resources in relation to NTDs, and infectious and chronic diseases.
They state that it is unlikely that surplus household income is available for prevention. Household expenditures relate to all major health events – including strokes, infarctions, neglected tropical diseases, major infections, injuries, and cancers. Many households become poor due to income loss from illness. Health safety nets such as insurance in advancing systems provide broader coverages. In fragile communities societal safety nets may cover all types of events as food shortages and disasters. Secondly, they explain that use of medicines is influenced by general awareness, health literacy, service quality, and the quality of workers. This is all important as increased availability may lead to misuse.
They acknowledge that universal access to medicine promotion has to address these multiple obstacles in the provision of appropriate care to communities. At national level, options for policy-makers are price control measures, price management of generic medicines and promotion of market entry through flexible TRIPS arrangements and licensing, and internal reference pricing of generic. An increase in international co-ordinated actions, such as mass production of low-cost antiretroviral drugs and the mass drug provision in the control of neglected tropical diseases is needed. Low cost treatments are possible for many conditions through mass production.
Read more: LSTM’s health economists call for strategies for universal access to medicines
The Latest on: Universal access to medicines
[google_news title=”” keyword=”Universal access to medicines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Universal access to medicines
- Ottawa says pharmacare is coming — here's what you need to knowon April 26, 2024 at 1:01 am
The federal government’s budget is setting aside $1.5 billion to implement pharmacare – a major financial commitment with the potential to have a wide-ranging impact on the country’s health-care ...
- WHO welcomes Spain’s Secretary of State for Health to discuss health prioritieson April 25, 2024 at 11:39 pm
WHO welcomed Mr Javier Padilla Bernáldez, Spain’s Secretary of State for Health and his delegation on 23 and 24 April 2024 to discuss joint global health priorities. Amongst others, Spain's focus is ...
- Pros and cons of universal health careon April 24, 2024 at 8:01 am
Con: longer wait times "Long waits for care are endemic to government-run, single-payer systems like the NHS," wrote Sally Pipes, CEO of free market think tank the Pacific Researc ...
- Millions of Medicare Recipients Could Gain Access to Weight-Loss Drugon April 24, 2024 at 7:56 am
The FDA's approval of a new use for Wegovy potentially opens up access to the drug for more than 3 million people on Medicare, according to a new study.
- National pharmacare will reduce access to new medicines for 27 million privately insured Canadianson April 18, 2024 at 5:43 am
The federal Liberal-NDP coalition government recently announced it would work with the provinces to fund universal prescription drug benefits for contraceptives and diabetes medications. It is the ...
- Opinion: Amid Canada's mental health care crisis, it's time to prioritize universal access to medicationon April 17, 2024 at 6:04 pm
From an economic perspective, investing in mental health care, including medication coverage, yields high returns by reducing hospitalizations, emergency room visits, and the need for more intensive, ...
- Food Is Medicine: The Road To Universal Coverageon April 9, 2024 at 11:55 am
Collectively, these steps would make FIM a near universal health care benefit ... range of entities on strategies for improving access to food is medicine. The views express here are their own.
- Access to genomic medicine illustrates precision medicine’s delicate futureon April 8, 2024 at 11:18 am
focused on equal access, patient autonomy, and affordability of genomic medicine – specifically, on multigene panel testing for cancer. They compared the testing’s status in their respective ...
- Access to genomic medicine illustrates precision medicine's delicate futureon April 7, 2024 at 5:00 pm
As genomics and precision medicine advances open new avenues for ... if only people have access to them. New research has now delved into the challenge of accessing innovative care.
- When it comes to access to medicines, no one should be left behindon February 19, 2024 at 8:41 am
Access to medicines, he adds ... Today’s activities contribute to the ultimate fulfillment of Universal Healthcare where health equity is one of its guiding principles.” ...
via Bing News